Tuesday, July 28th | 12:00 PM ET, 6:00 PM CET

As wearable technologies become increasingly validated in Parkinson's disease care, the conversation is shifting from whether they work to how they can be successfully integrated into everyday clinical practice.

Join Dr. Ritesh Ramdhani and Empatica's Chase Babcock for a panel discussion exploring how healthcare organizations are implementing wearable monitoring to support clinical decision-making, streamline remote patient monitoring, and build sustainable care models. Through real-world case examples and practical implementation strategies, this session will examine how wearable technologies can help clinicians deliver more personalized, data-driven care while preparing for the future of neurology.

 

What we’ll cover:

  • How wearable monitoring is transforming Parkinson's care from validation to routine clinical practice
  • Real-world examples of wearable-informed treatment decisions
  • Integrating wearable data into routine neurology workflows
  • RPM reimbursement and sustainable implementation models
  • Scaling adoption across diverse clinical settings
  • Future opportunities for wearable-enabled Parkinson's care


Secure your spot
Join us to learn how leading clinicians are moving beyond research and successfully integrating wearable monitoring into Parkinson's disease care.

Register to attend

By clicking Register you consent to being contacted by Empatica Inc. about its products and services and you agree to the terms and conditions stated in the privacy policy.

Our special guests

Ritesh Ramdhani, MD, is an Associate Professor of Neurology and clinician-scientist with expertise in Parkinson's disease and movement disorders, deep brain stimulation, and digital health technologies. He serves as Director of the Deep Brain Stimulation Program and the Parkinson's and Movement Disorders Division at Northwell Health in New York. His research has been funded by the National Institutes of Health, and he holds a patent related to data-driven, wearable-based approaches to optimizing Parkinson's disease management. Dr. Ramdhani leads clinical trials and investigator-initiated studies focused on leveraging wearable sensors, adaptive neuromodulation, and artificial intelligence to advance personalized care for people with Parkinson's disease.

 

Our host

 

About Empatica

Empatica Inc. is a pioneer in continuous, unobtrusive remote health monitoring driven by AI. 
Empatica's FDA-cleared platform and technology are used by thousands of institutional partners for research purposes, in studies examining stress, sleep, epilepsy, migraine, depression, addiction, and other conditions. Its flagship medical wearable, EmbracePlus, has been developed with key partners including HHS, USAMRDC, and the NASA-funded TRISH. Its latest device, EmbraceMini, is the world’s smallest actigraphy device for use in clinical care and research. Empatica is also a global leader in patient-centric wearable epilepsy monitoring. In 2025, Empatica acquired PKG Health, expanding its offering into Parkinson’s Disease.